<乌鸦传媒>Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<乌鸦传媒>Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<乌鸦传媒>Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
<乌鸦传媒>Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
<乌鸦传媒>Op-Ed: Dermatology Needs Lower Costs and Better Care A proposal for value-based care Apr 21, 2021
<乌鸦传媒>Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<乌鸦传媒>A Win for Adjuvant Immunotherapy in Esophageal Cancer And other highlights from the Society of Surgical Oncology's virtual 2021 meeting Mar 31, 2021
<乌鸦传媒>Want Data on Recently Approved Actinic Keratosis Drug? Here You Go Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<乌鸦传媒>First Immunotherapy Approved for Basal Cell Carcinoma Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<乌鸦传媒>IL-8 Antibody Active in Tumors After PD-1/L1 Blockade Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<乌鸦传媒>PD-1 Inhibitor Active in Progressive Basal Cell Cancer Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<乌鸦传媒>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Combo Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<乌鸦传媒>Demographics Make a Difference in Common Skin Cancers Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<乌鸦传媒>Calcineurin Blockers for Eczema: No Cancer Signal in Big Study "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<乌鸦传媒>Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<乌鸦传媒>Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<乌鸦传媒>Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<乌鸦传媒>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens Trial looked at effects of a free "UV-selfie" app May 07, 2020
<乌鸦传媒>6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
<乌鸦传媒>Triplet Succeeds in BRAF-Mutant Melanoma Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020
<乌鸦传媒>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>Staving Off Sepsis; Bleeding and Fibroids: It's Double T Healthwatch! This week's topics also include blood levels of sunscreen ingredients, and fish oil and sperm quality Jan 25, 2020 podcast
<乌鸦传媒>'Surprising' Number of Cancer Survivors Use Alcohol Clinicians urged to step up alcohol screening at regular intervals, intervention Jan 22, 2020
<乌鸦传媒>What Is Causing This Woman's Swollen Chin? A long and challenging diagnostic path with twists and turns Jan 20, 2020
<乌鸦传媒>Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
<乌鸦传媒>Second Primary Melanoma Increases Risk for Death Data a reminder of the importance of regular skin exams Jun 27, 2019
<乌鸦传媒>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
<乌鸦传媒>Depth of Tumor Response a Better Survival Predictor Could improve on RECIST as outcome measure in oncology Jun 05, 2019
<乌鸦传媒>Predicting Disease Recurrence in Melanoma But time to recurrence may poorly correlate with survival May 03, 2019
<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<乌鸦传媒>Reversing Melanoma Resistance to Immunotherapy HDAC inhibitor/anti-PD-1 combo active after initial anti-PD-1 failure Apr 02, 2019 video
<乌鸦传媒>Cancer Drug for Precancerous Lesions? Fluorouracil cream bested other common actinic keratosis treatments Mar 08, 2019
<乌鸦传媒>Do Keloids Convey a Higher Cancer Risk? Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
<乌鸦传媒>V600K-Mutant Melanoma May Merit First-Line Immunotherapy Higher mutational load is less responsive to targeted therapy with BRAF/MEK inhibition Jan 10, 2019
<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<乌鸦传媒>NCRI: Highlights from the Annual Conference Prostate cancer tradeoffs, rising melanoma mortality, safer regimen for thyroid cancer Nov 05, 2018
<乌鸦传媒>Ideal Timing of Post-Mohs Reconstruction Waiting 7 days or more associated with reduced complications Oct 26, 2018
<乌鸦传媒>Frequent Basal Cell Cancers Sign of Broader Inherited Risk Tripled rates of internal malignancies such as breast and prostate tumors Aug 10, 2018
<乌鸦传媒>Study: Paclitaxel Best for HIV-Related Kaposi's Sarcoma Other chemotherapies fall behind in resource-limited setting Jul 29, 2018
